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Zika virus infection in humans is usu-
ally mild or asymptomatic. However, 
some babies born to women infected 
with Zika virus have severe neurologi-
cal sequelae. An unusual cluster of cases 
of congenital microcephaly and other 
neurological disorders in the WHO 
Region of the Americas, led to the dec-
laration of a public health emergency 
of international concern by the World 
Health Organization (WHO) on 1 Feb-
ruary 2016. By 5 May 2016, reports of 
newborns or fetuses with microcephaly 
or other malformations – presumably 
associated with Zika virus infection – 
have been described in the following 
countries and territories: Brazil (1271 
cases); Cabo Verde (3 cases); Colombia 
(7 cases); French Polynesia (8 cases); 
Martinique (2 cases) and Panama (4 
cases). Additional cases were also re-
ported in Slovenia and the United States 
of America, in which the mothers had 
histories of travel to Brazil during their 
pregnancies.1
Zika virus is an intensely neuro-
tropic virus that particularly targets 
neural progenitor cells but also – to a 
lesser extent – neuronal cells in all stages 
of maturity. Viral cerebritis can disrupt 
cerebral embryogenesis and result in 
microcephaly and other neurological 
abnormalities.2 Zika virus has been iso-
lated from the brains and cerebrospinal 
fluid of neonates born with congenital 
microcephaly and identified in the pla-
cental tissue of mothers who had had 
clinical symptoms consistent with Zika 
virus infection during their pregnan-
cies.3–5 The spatiotemporal association 
of cases of microcephaly with the Zika 
virus outbreak and the evidence emerg-
ing from case reports and epidemiologic 
studies, has led to a strong scientific 
consensus that Zika virus is implicated 
in congenital abnormalities.6,7
Existing evidence and unpublished 
data shared with WHO highlight the 
wider range of congenital abnormalities 
probably associated with the acquisi-
tion of Zika virus infection in utero. In 
addition to microcephaly, other mani-
festations include craniofacial dispro-
portion, spasticity, seizures, irritability 
and brainstem dysfunction including 
feeding difficulties, ocular abnormali-
ties and findings on neuroimaging such 
as calcifications, cortical disorders and 
ventriculomegaly.3–6,8–10 Similar to other 
infections acquired in utero, cases range 
in severity; some babies have been re-
ported to have neurological abnormali-
ties with a normal head circumference. 
Preliminary data from Colombia and 
Panama also suggest that the genito-
urinary, cardiac and digestive systems 
can be affected (Pilar Ramon-Pardo, 
unpublished data).
The range of abnormalities seen and 
the likely causal relationship with Zika 
virus infection suggest the presence of 
a new congenital syndrome. WHO has 
set in place a process for defining the 
spectrum of this syndrome. The process 
focuses on mapping and analysing the 
clinical manifestations encompassing 
the neurological, hearing, visual and 
other abnormalities, and neuroimaging 
findings. WHO will need good antenatal 
and postnatal histories and follow-up 
data, sound laboratory results, exclusion 
of other etiologies and analysis of imag-
ing findings to properly delineate this 
syndrome. The scope of the syndrome 
will expand as further information and 
longer follow-up of affected children 
become available. The surveillance 
system that was established as part of 
the epidemic response to the outbreak 
initially called only for the reporting of 
microcephaly cases. This surveillance 
guidance has been expanded to include 
a spectrum of congenital malformations 
that could be associated with intrauter-
ine Zika virus infection.11
Effective sharing of data is needed 
to define this syndrome. A few reports 
have described a wide range of abnor-
malities,3–6,8–10 but most data related to 
congenital manifestations of Zika infec-
tion remain unpublished. Global health 
organizations and research funders 
have committed to sharing data and 
results relevant to the Zika epidemic as 
openly as possible.12 Further analysis of 
data from cohorts of pregnant women 
with Zika virus infection are needed to 
understand all outcomes of Zika virus 
infection in pregnancy.
Thirty-seven countries and territo-
ries in the Region of the Americas now 
report mosquito-borne transmission of 
Zika virus and risk of sexual transmis-
sion. With such spread, it is possible that 
many thousands of infants will incur 
moderate to severe neurological dis-
abilities. Therefore, routine surveillance 
systems and research protocols need to 
include a larger population than simply 
children with microcephaly. The health 
system response, including psychosocial 
services for women, babies and affected 
families will need to be fully resourced.
The Zika virus public health emer-
gency is distinct because of its long-term 
health consequences and social impact. 
A coordinated approach to data sharing, 
surveillance and research is needed. 
WHO has thus started coordinating ef-
forts to define the congenital Zika virus 
syndrome and issues an open invitation 
to all partners to join in this effort. ■
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